Bitter melon (Momordica charantia) attenuates atherosclerosis in apo-E knock-out mice possibly through reducing triglyceride and anti-inflammation

scientific article published on 06 November 2018

Bitter melon (Momordica charantia) attenuates atherosclerosis in apo-E knock-out mice possibly through reducing triglyceride and anti-inflammation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1186/S12944-018-0896-0
P932PMC publication ID6220495
P698PubMed publication ID30400958

P2093author name stringLingling Xu
Yaoming Xue
Meiping Guan
Jimin Li
Chenzhong Li
Yanmei Zeng
Zhongji Zheng
P2860cites workActivation of AMPK by bitter melon triterpenoids involves CaMKKβQ28486994
Citrullus lanatus 'sentinel' (watermelon) extract reduces atherosclerosis in LDL receptor-deficient miceQ30558177
Role of inflammatory mediators in thrombogenesisQ34542369
Momordica charantia (bitter melon) attenuates high-fat diet-associated oxidative stress and neuroinflammationQ35086140
Bioactives from bitter melon enhance insulin signaling and modulate acyl carnitine content in skeletal muscle in high-fat diet-fed mice.Q35103622
Anti-inflammatory effect of Momordica charantia in sepsis miceQ35231058
The role of triglycerides in atherosclerosisQ35602424
Anti-inflammatory effects of a Chinese herbal medicine in atherosclerosis via estrogen receptor β mediating nitric oxide production and NF-κB suppression in endothelial cellsQ36738086
Protective effects of AMP‐activated protein kinase in the cardiovascular systemQ37793322
Wild Bitter Melon Leaf Extract Inhibits Porphyromonas gingivalis-Induced Inflammation: Identification of Active Compounds through Bioassay-Guided Isolation.Q38779824
TRIGLYCERIDES, ATHEROSCLEROSIS, AND CARDIOVASCULAR OUTCOME STUDIES: FOCUS ON OMEGA-3 FATTY ACIDS.Q39000699
Does bitter melon contain an activator of AMP-activated kinase?Q39231648
Genetics of Triglycerides and the Risk of AtherosclerosisQ39324048
EMCD, a hypoglycemic triterpene isolated from Momordica charantia wild variant, attenuates TNF-α-induced inflammation in FL83B cells in an AMP-activated protein kinase-independent mannerQ39334183
AMP-activated protein kinase suppresses endothelial cell inflammation through phosphorylation of transcriptional coactivator p300.Q39469473
Activating effect of momordin, extract of bitter melon (Momordica Charantia L.), on the promoter of human PPARdeltaQ39759452
A cell-based screening identifies compounds from the stem of Momordica charantia that overcome insulin resistance and activate AMP-activated protein kinaseQ39957131
Inhibitory effects of myricitrin on oxidative stress-induced endothelial damage and early atherosclerosis in ApoE-/- miceQ42711552
Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathwayQ42815451
Atherosclerosis-preventing activity of lactic acid bacteria-fermented milk-soymilk supplemented with Momordica charantiaQ46122437
Momordica charantia polysaccharides ameliorate oxidative stress, inflammation, and apoptosis in ethanol-induced gastritis in mucosa through NF-kB signaling pathway inhibition.Q47226159
Increased expression of adhesion molecules in uremic atherosclerosis in apolipoprotein-E-deficient miceQ47578369
Regression of atherosclerosis: lessons learned from genetically modified mouse modelsQ49709124
Momordica charantia ameliorates insulin resistance and dyslipidemia with altered hepatic glucose production and fatty acid synthesis and AMPK phosphorylation in high-fat-fed mice.Q51050646
Relationship between serum triglyceride levels and endothelial function in a large community-based study.Q51377710
Supplementation of bitter melon to rats fed a high-fructose diet during gestation and lactation ameliorates fructose-induced dyslipidemia and hepatic oxidative stress in male offspring.Q51430168
Soluble adhesion molecules and the search for biomarkers for atherosclerosisQ74605910
Mechanisms underlying decreased hepatic triacylglycerol and cholesterol by dietary bitter melon extract in the ratQ83762705
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectMomordica charantiaQ428750
atherosclerosisQ12252367
triglycerideQ186319
P304page(s)251
P577publication date2018-11-06
P1433published inLipids in Health and DiseaseQ15756695
P1476titleBitter melon (Momordica charantia) attenuates atherosclerosis in apo-E knock-out mice possibly through reducing triglyceride and anti-inflammation
P478volume17

Reverse relations

Q64257123, a Nutraceutical Approach for Inflammatory Related Diseasescites workP2860